Yixintang Pharmaceutical (002727.SZ) has completed its repurchase, with a total expenditure of 150 million yuan to repurchase 1.96% of its shares.
Yi Xin Tang (002727.SZ) announced that the company's share repurchase plan has been successfully completed. As of March 5, 2025...
Yixintang Pharmaceutical (002727.SZ) announced that the implementation of the company's share repurchase plan has been completed. As of March 5, 2025, the company has repurchased a total of 11.4759 million shares through centralized bidding transactions, accounting for 1.96% of the company's current total share capital, with a total transaction amount of 150 million yuan (excluding transaction fees).
Related Articles

Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


